Brainstorm announces first quarter 2021 financial results and provides a corporate update

New york, april 26, 2021 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced today financial results for the first quarter ended march 31, 2021 and provided a corporate update. "in the first quarter we were excited to announce positive top line data from our phase 2 trial evaluating nurown ® as a treatment for progressive multiple sclerosis (ms).
BCLI Ratings Summary
BCLI Quant Ranking